アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/11/15 | 1,672.5 | 1,692 | 1,668.5 | 1,670.5 | +3 | +0.2% | 7,002,400 |
2024/11/14 | 1,685 | 1,687 | 1,667.5 | 1,667.5 | -2.5 | -0.1% | 4,814,200 |
2024/11/13 | 1,705 | 1,706.5 | 1,663.5 | 1,670 | -39.5 | -2.3% | 8,468,300 |
2024/11/12 | 1,738.5 | 1,746.5 | 1,701.5 | 1,709.5 | -20 | -1.2% | 5,805,800 |
2024/11/11 | 1,715.5 | 1,730.5 | 1,711 | 1,729.5 | +14 | +0.8% | 3,854,100 |
2024/11/08 | 1,751.5 | 1,752.5 | 1,713 | 1,715.5 | -19 | -1.1% | 4,949,800 |
2024/11/07 | 1,735 | 1,745 | 1,712.5 | 1,734.5 | -8.5 | -0.5% | 6,292,000 |
2024/11/06 | 1,735 | 1,774.5 | 1,731.5 | 1,743 | +14 | +0.8% | 5,983,900 |
2024/11/05 | 1,700 | 1,747.5 | 1,699.5 | 1,729 | -52.5 | -2.9% | 7,318,000 |
2024/11/01 | 1,769.5 | 1,796.5 | 1,762 | 1,781.5 | -14 | -0.8% | 4,864,900 |
2024/10/31 | 1,809 | 1,810.5 | 1,763.5 | 1,795.5 | +6.5 | +0.4% | 10,152,700 |
2024/10/30 | 1,790 | 1,803 | 1,780 | 1,789 | -1.5 | -0.1% | 11,665,600 |
2024/10/29 | 1,747.5 | 1,792 | 1,741 | 1,790.5 | +55 | +3.2% | 6,313,800 |
2024/10/28 | 1,696.5 | 1,749 | 1,692.5 | 1,735.5 | -1 | -0.1% | 5,818,600 |
2024/10/25 | 1,757.5 | 1,760 | 1,728 | 1,736.5 | -24.5 | -1.4% | 2,757,500 |
2024/10/24 | 1,762.5 | 1,774 | 1,758 | 1,761 | -1 | -0.1% | 4,069,200 |
2024/10/23 | 1,768 | 1,782.5 | 1,759 | 1,762 | -16 | -0.9% | 3,248,600 |
2024/10/22 | 1,786 | 1,786 | 1,760 | 1,778 | -7 | -0.4% | 3,554,900 |
2024/10/21 | 1,762 | 1,788 | 1,755 | 1,785 | +23 | +1.3% | 4,305,000 |
2024/10/18 | 1,750 | 1,772 | 1,744.5 | 1,762 | +29 | +1.7% | 3,711,700 |
2024/10/17 | 1,723.5 | 1,741 | 1,717 | 1,733 | +22 | +1.3% | 4,528,300 |
2024/10/16 | 1,710 | 1,731.5 | 1,695 | 1,711 | -14.5 | -0.8% | 3,780,500 |
2024/10/15 | 1,747.5 | 1,756.5 | 1,723.5 | 1,725.5 | -25 | -1.4% | 4,950,300 |
2024/10/11 | 1,744 | 1,753.5 | 1,738.5 | 1,750.5 | -15.5 | -0.9% | 5,450,600 |
2024/10/10 | 1,761 | 1,771 | 1,750 | 1,766 | +19 | +1.1% | 2,951,800 |
2024/10/09 | 1,759.5 | 1,762 | 1,727 | 1,747 | +3 | +0.2% | 3,475,600 |
2024/10/08 | 1,747 | 1,751 | 1,717.5 | 1,744 | -15 | -0.9% | 5,461,400 |
2024/10/07 | 1,747 | 1,767 | 1,728.5 | 1,759 | +31 | +1.8% | 5,004,100 |
2024/10/04 | 1,720 | 1,729.5 | 1,714.5 | 1,728 | +5.5 | +0.3% | 3,360,400 |
2024/10/03 | 1,706.5 | 1,729 | 1,705 | 1,722.5 | +43 | +2.6% | 4,579,600 |
2024/10/02 | 1,666.5 | 1,679.5 | 1,659 | 1,679.5 | +3 | +0.2% | 4,378,600 |
2024/10/01 | 1,650 | 1,677 | 1,645.5 | 1,676.5 | +29.5 | +1.8% | 4,448,400 |
2024/09/30 | 1,650 | 1,653 | 1,621 | 1,647 | -62.5 | -3.7% | 8,602,100 |
2024/09/27 | 1,690 | 1,710.5 | 1,670 | 1,709.5 | -9.5 | -0.6% | 7,305,000 |
2024/09/26 | 1,729 | 1,732.5 | 1,704 | 1,719 | -21 | -1.2% | 9,414,000 |
2024/09/25 | 1,740 | 1,746 | 1,726 | 1,740 | +16.5 | +1% | 5,364,000 |
2024/09/24 | 1,750 | 1,758.5 | 1,723.5 | 1,723.5 | -13.5 | -0.8% | 5,755,300 |
2024/09/20 | 1,749.5 | 1,758 | 1,731 | 1,737 | +5 | +0.3% | 7,208,300 |
2024/09/19 | 1,743 | 1,761.5 | 1,716.5 | 1,732 | +22.5 | +1.3% | 5,966,700 |
2024/09/18 | 1,696 | 1,719.5 | 1,689.5 | 1,709.5 | +20.5 | +1.2% | 5,122,200 |
2024/09/17 | 1,718 | 1,721 | 1,643.5 | 1,689 | -16 | -0.9% | 13,870,600 |
2024/09/13 | 1,784.5 | 1,805 | 1,698.5 | 1,705 | -84.5 | -4.7% | 11,212,800 |
2024/09/12 | 1,788.5 | 1,814.5 | 1,785.5 | 1,789.5 | +10.5 | +0.6% | 4,828,500 |
2024/09/11 | 1,799.5 | 1,805 | 1,768.5 | 1,779 | -12 | -0.7% | 4,952,100 |
2024/09/10 | 1,820 | 1,824.5 | 1,788.5 | 1,791 | -24 | -1.3% | 6,105,700 |
2024/09/09 | 1,788 | 1,820 | 1,772.5 | 1,815 | +14 | +0.8% | 4,246,500 |
2024/09/06 | 1,795 | 1,813.5 | 1,795 | 1,801 | +6.5 | +0.4% | 4,454,300 |
2024/09/05 | 1,762 | 1,802 | 1,756 | 1,794.5 | -4 | -0.2% | 4,682,700 |
2024/09/04 | 1,772.5 | 1,798.5 | 1,768.5 | 1,798.5 | -21.5 | -1.2% | 5,693,000 |
2024/09/03 | 1,790 | 1,821.5 | 1,786 | 1,820 | +28 | +1.6% | 3,609,200 |
51~
100
件表示中 / 3631件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 151,400円 | +18.5% | -96.0% | 4.89% | 193.61倍 | 1.77倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 420,900円 | +7.7% | +206.9% | 4.66% | 56.54倍 | 0.96倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 813,600円 | +14.4% | +120.8% | 1.47% | 18.21倍 | 1.67倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 229,000円 | +5.7% | +3.9% | 2.50% | 11.39倍 | 1.51倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 462,100円 | +1.7% | -2.9% | 3.46% | 30.32倍 | 1.59倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム